DAGAPAMIL

Details

Stereochemistry	RACEMIC
Molecular Formula	C36H56N2O4
Molecular Weight	580.8408
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCCCCCCCCCCCC(CCCN(C)CCC1=CC=CC(OC)=C1)(C#N)C2=CC(OC)=C(OC)C(OC)=C2

InChI

InChIKey=BGCVNLXQFOHWMO-UHFFFAOYSA-N

InChI=1S/C36H56N2O4/c1-7-8-9-10-11-12-13-14-15-16-22-36(29-37,31-27-33(40-4)35(42-6)34(28-31)41-5)23-18-24-38(2)25-21-30-19-17-20-32(26-30)39-3/h17,19-20,26-28H,7-16,18,21-25H2,1-6H3

HIDE SMILES / InChI

Description
Sources: https://patents.google.com/patent/GB2100252B/en | https://books.google.com/books?lr=&id=y7DtCAAAQBAJ&oi=fnd&pg=PA1&dq=DAGAPAMIL

Dagapamil is a calcium-channel blocker, discovered by BASF. The compound is claimed to have antihypertensive, antiarrhythmic, cardioprotective, antiallergic and platelet aggregation-inhibiting action in animal models.

Approval Year

Name

Type

Language

DAGAPAMIL

Official Name

English

2-(3-((M-METHOXYPHENETHYL)METHYLAMINO)PROPYL)-2-(3,4,5-TRIMETHOXYPHENYL)TETRADECANENITRILE

Systematic Name

English

(±)-DAGAPAMIL

Common Name

English

DAGAPAMIL, (±)-

Common Name

English

dagapamil [INN]

Common Name

English

BENZENEACETONITRILE, .ALPHA.-DODECYL-3,4,5-TRIMETHOXY-.ALPHA.-(3-((2-(3-METHOXYPHENYL)ETHYL)METHYLAMINO)PROPYL)-

Systematic Name

English

Classification Tree Code System Code

NCI_THESAURUS

C333